Description

DILZEM CD 180 MG

Indications

DILZEM CD 180 MG is primarily indicated for the management of hypertension (high blood pressure) and the treatment of certain types of angina pectoris (chest pain). It may also be utilized in the management of certain cardiac arrhythmias. The active ingredient, diltiazem, belongs to the class of medications known as calcium channel blockers, which help to lower blood pressure and reduce the workload on the heart by relaxing the blood vessels.

Mechanism of Action

Diltiazem, the active component of DILZEM CD, exerts its therapeutic effects by inhibiting the influx of calcium ions into cardiac and smooth muscle cells through voltage-gated calcium channels. This action leads to relaxation of vascular smooth muscle, resulting in vasodilation and decreased peripheral vascular resistance. Additionally, diltiazem decreases the force of contraction of the heart muscle and slows down the conduction through the atrioventricular (AV) node, which can help regulate heart rhythm. The combined effects contribute to reduced myocardial oxygen demand and improved coronary blood flow, making it effective for both hypertension and angina.

Pharmacological Properties

DILZEM CD is characterized by its extended-release formulation, allowing for once-daily dosing. The pharmacokinetics of diltiazem include rapid absorption after oral administration, with peak plasma concentrations typically occurring within 2 to 3 hours. The drug is extensively metabolized in the liver, primarily by cytochrome P450 enzymes, leading to various metabolites, some of which retain pharmacological activity. The elimination half-life of diltiazem ranges from 3 to 5 hours, although the extended-release formulation prolongs its therapeutic effects. The drug is excreted primarily through urine, with a small fraction eliminated unchanged.

Contraindications

DILZEM CD should not be used in patients with known hypersensitivity to diltiazem or any of its components. It is contraindicated in individuals with severe bradycardia (slow heart rate), advanced atrioventricular block (unless the patient has a functioning pacemaker), and severe hypotension (low blood pressure). Additionally, caution is advised in patients with a history of heart failure, liver dysfunction, or renal impairment, as these conditions may affect the drug’s metabolism and excretion.

Side Effects

Common side effects associated with DILZEM CD include dizziness, headache, fatigue, and flushing. Gastrointestinal disturbances such as nausea, constipation, and abdominal discomfort may also occur. More serious adverse effects, though less common, can include hypotension, bradycardia, and heart block. Patients should be monitored for signs of liver dysfunction, as elevated liver enzymes may occur. Allergic reactions, although rare, can manifest as rash, itching, or swelling. It is essential for patients to report any unusual or severe side effects to their healthcare provider promptly.

Dosage and Administration

The typical starting dose of DILZEM CD for adults is 120 to 240 mg once daily, depending on the severity of the condition being treated and the patient’s response to therapy. The maximum recommended dose is 360 mg per day. It is crucial to adhere to the prescribed dosing regimen and not to exceed the recommended dose without consulting a healthcare provider. DILZEM CD should be taken with or without food, but it is advisable to take it at the same time each day to maintain consistent blood levels of the medication. The extended-release formulation should not be crushed or chewed, as this can alter the release characteristics of the drug.

Interactions

DILZEM CD may interact with several other medications, potentially altering their effects. Co-administration with other antihypertensive agents may lead to additive effects, resulting in hypotension. Caution is advised when using diltiazem with beta-blockers, as this combination can increase the risk of bradycardia and heart block. Additionally, diltiazem can inhibit the metabolism of certain drugs metabolized by cytochrome P450 3A4, such as statins, leading to increased plasma concentrations and potential toxicity. Patients should inform their healthcare provider of all medications, including over-the-counter drugs and herbal supplements, to avoid potential interactions.

Precautions

Before initiating therapy with DILZEM CD, a thorough medical history and physical examination should be conducted. Special caution should be exercised in patients with pre-existing heart conditions, liver or kidney impairment, and those who are elderly. Regular monitoring of blood pressure and heart rate is recommended to ensure the safety and efficacy of treatment. Patients should be advised to avoid abrupt discontinuation of the medication, as this may lead to rebound hypertension or exacerbation of angina symptoms. Alcohol consumption should be limited, as it may enhance the hypotensive effects of diltiazem.

Clinical Studies

Numerous clinical studies have evaluated the efficacy and safety of DILZEM CD in the management of hypertension and angina. In a randomized, double-blind, placebo-controlled trial, patients receiving DILZEM CD demonstrated significant reductions in systolic and diastolic blood pressure compared to placebo. Furthermore, studies have shown that diltiazem effectively reduces the frequency and severity of angina attacks, improving exercise tolerance in patients with stable angina. Long-term studies have indicated that DILZEM CD is well-tolerated, with a favorable side effect profile, making it a valuable option in the management of cardiovascular conditions.

Conclusion

DILZEM CD 180 MG is an effective medication for the management of hypertension and angina pectoris. Its unique mechanism of action as a calcium channel blocker allows for significant cardiovascular benefits, including reduced blood pressure and improved heart function. While generally well-tolerated, it is essential for patients to be aware of potential side effects and drug interactions. Regular follow-up with healthcare providers is crucial to ensure optimal treatment outcomes and to adjust therapy as needed. As with any medication, adherence to prescribed dosing and monitoring for adverse effects are fundamental to achieving the best results.